Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04260243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease

Study acronym: MFR-COPD
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Mar 2025 to Mar 2027
    • Start date: Mar 2024 to Mar 2026
    • Study completion date: Jun 2025 to Jun 2027
    v8
  2. Notable Start date: Sep 2023 to Mar 2024
    • Primary completion date: Sep 2024 to Mar 2025
    • Study completion date: Nov 2024 to Jun 2025
    v7
  3. Minor Re-verified, no change to tracked fieldsv6
  4. Notable Primary completion date: Sep 2023 to Sep 2024
    • Start date: Sep 2022 to Sep 2023
    • Study completion date: Nov 2023 to Nov 2024
    v5
  5. Notable Primary completion date: Dec 2021 to Sep 2023
    • Start date: Apr 2021 to Sep 2022
    • Study completion date: Dec 2021 to Nov 2023
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Start date: Oct 28, 2020 to Apr 2021
    • Primary completion date: Jun 22, 2021 to Dec 2021
    • Study completion date: Jul 5, 2021 to Dec 2021
    v3
  2. Notable Primary endpoint revised
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoint revised
    • Study description revised
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).
Trial Details
NCT Number NCT04260243
Lead Sponsor Cardenal Herrera University
Conditions
(from sponsor)
Copd
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov